How manyaminoacids insemaglutide Semaglutide, a significant advancement in the management of type 2 diabetes and chronic weight management, is a de novo designed peptide analogue of glucagon-like peptide-1 (GLP-1). Understanding its precise *semaglutide structure with amino acid sequence* is crucial for appreciating its pharmacological profile and therapeutic efficacy. This article delves into the intricate details of the semaglutide structure, examining its amino acid sequence, chemical composition, and the key modifications that distinguish it from its natural counterpart, GLP-1作者:A Amini·2025—Semaglutide consists of alinear sequence of 31 amino acids, including two arginine residues and one lysine residue conjugated to a long-chain ....
At its core, Semaglutide is a synthetic peptide characterized by a linear sequence of 31 amino acids. While structurally similar to human GLP-1, it is not an exact replicaMolecular mechanisms of semaglutide and liraglutide as a .... Native human GLP-1 is a 30 amino acid peptide hormone. A key feature of semaglutide is its 94% amino acid sequence homology with native human GLP-1 (7-37). This high degree of similarity underpins its mechanism of action as a GLP-1 receptor agonist.
The precise amino acid sequence of semaglutide is a critical element in its biological function. The sequence, often referenced from sources like PubChem, is numbered from 7 to 37, aligning with the numbering of the human GLP-1 (7-37) peptide. While some sources describe it as a synthetic peptide consisting of 39 amino acids, the functional therapeutic peptide is generally understood to be the 31-amino acid moiety. Let's explore the specific amino acids and their arrangement:
The semaglutide sequence begins with Histidine (H) and incorporates a unique modification at position 8 with alpha-aminoisobutyric acid (Aib), replacing the native Alanine found in GLP-1Semaglutide [LTP-V028]. This substitution is a significant departure from the natural hormone. The sequence continues with Glutamic acid (E), Glycine (G), Threonine (T), Phenylalanine (F), Threonine (T), Serine (S), Aspartic acid (D), Valine (V), Serine (S), Serine (S), Tyrosine (Y), Leucine (L), Glutamic acid (E), Glycine (G), Glutamine (Q), Alanine (A), Alanine (A), [modified amino acid], Threonine (T), Serine (S), Aspartic acid (D), Serine (S), Serine (S), Tyr (Y), Leu (L), Glu (E), Gly (G), Gln (Q), Ala (A), and finally, Arginine (R).
A notable modification also occurs at position 34, where the native Arginine is retainedMolecular mechanisms of semaglutide and liraglutide as a .... However, the detailed numbering and specific substitutions can vary slightly depending on the referenced source, with some including the full sequence and others focusing on the modified regions. For instance, it is chemically known as H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Arg-Gly-OH.
The Formula. C187H291N45O59 represents the molecular formula of semaglutide, highlighting its complex polypeptide nature. The molecular weight is approximately 4113.58 grams per moleSemaglutide(Semaglutide) is a novel long-acting GLP-1 analogue, and the peptidesequenceof theSemaglutideis as follows: his (His)1-Aib2-Glu3-Gly4-Thr5- .... This precise chemical makeup contributes to its pharmacokinetic properties, including its prolonged half-life.
The amino acids at positions 8 and 34 are particularly significantSemaglutide(Semaglutide) is a novel long-acting GLP-1 analogue, and the peptidesequenceof theSemaglutideis as follows: his (His)1-Aib2-Glu3-Gly4-Thr5- .... The replacement of the second amino acid (position 8 in the mature 7-37 peptide hormone) with a non-canonical amino acid in position 8, specifically Aib, is a key structural alteration. This, along with a further modification involving the attachment of a fatty acid (often a stearic acid derivative) to the lysine residue at position 26 (or Lys20 depending on the numbering convention used in the literature) via a glutamic acid spacer, contributes to semaglutide's enhanced stability against enzymatic degradation (by DPP-4) and its increased binding to albumin, thereby extending its duration of action. This Semaglutide Chemical Structure with its modifications is what allows for its once-weekly dosing regimen.2025年12月22日—Amino Acid Sequence and Structural Modifications.Semaglutide consists of 31 amino acids, with substitutions and conjugations enhancing ...
The structures of semaglutide have been elucidated through various techniques, including cryoelectron microscopy (cryo-EM), providing a deeper understanding of its interaction with the GLP-1 receptorA polypeptide that contains alinear sequence of 31 amino acidsjoined together by peptide linkages. It is an agonist of glucagon-like peptide-1 receptors .... These studies often incorporate detailed visual representations of the peptide, showing its two α-helices from amino acid position 13–20 and 24–35 separated by a linker region, which are characteristic features of GLP-1 receptor agonists.
The amino acid sequence is not merely a list of building blocks; it dictates the three-dimensional folding and ultimately the biological activity of the molecule.Semaglutide is a polypeptide that contains alinear sequence of 31 amino acidsjoined together by peptide linkages. It is an agonist of glucagon-like peptide-1 ... The scientific community continues to explore the nuances of the semaglutideX sequence and its implications2017 FDA Peptide Harvest - PMC - PubMed Central - NIH. The available data, including experimental structures, supports the understanding of semaglutide as a peptide composed of 31 amino acids, engineered for improved therapeutic outcomes.Semaglutide(Semaglutide) is a novel long-acting GLP-1 analogue, and the peptidesequenceof theSemaglutideis as follows: his (His)1-Aib2-Glu3-Gly4-Thr5- ...
In summary, the semaglutide structure with amino acid sequence is a testament to sophisticated peptide engineering. The linear sequence of 31 amino acids, with strategic modifications at key positions like the inclusion of a non-canonical amino acid in position 8 and the fatty acid acylation, enhances its stability and bioavailability. This intricate design underpins semaglutide's role as a potent GLP-1 receptor agonist, offering significant benefits for individuals managing type 2 diabetes and obesity2017年12月6日—Semaglutideis a glucagon-like peptide 1 (GLP-1) analogused to manage type 2 diabetes along with lifestyle changes, such as dietary restrictions and increased .... The precise chemical formula, Formula. C187H291N45O59, encapsulates the complexity of this therapeutic peptide.
Join the newsletter to receive news, updates, new products and freebies in your inbox.